Investor Home

Corporate Profile

Apricus is committed to developing sexual health therapies in areas of high unmet needs. We have disciplined leadership focused on execution and are driving near-term shareholder value through regulatory approval, commercialization and partnering initiatives.

Recent Newsmore >
DateTitle
09/28/16Apricus Biosciences Closes $3.7 Million Registered Direct Offering
SAN DIEGO, Sept. 28, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it has closed a registered direct offering of shares of common stock with institutional investors for gross proceeds of approximately $3.7 million.  Based on feedback from the Nasdaq stock market, Apricus and the investors mutually agreed to revise the size of the offering such that fewer shares of co... 
09/23/16Apricus Biosciences Announces $4.6 Million Registered Direct Offering
SAN DIEGO, Sept. 23, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it has entered into a definitive agreement with institutional investors for an offering of shares of common stock with gross proceeds of approximately $4.6 million in a registered direct offering. The closing of the offering is expected to take place on or about September 27, 2016, subject to the sati... 
09/21/16Apricus Biosciences Announces the Launch of Vitaros® in the Czech Republic and Slovakia by Recordati
Continued Commercial Expansion in Europe Expected to Increase Royalty Revenue for Apricus SAN DIEGO, Sept. 21, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced the launch of Vitaros®, Apricus’ novel on-demand topical cream for the treatment of erectile dysfunction (ED), in the Czech Republic and Slovakia by Recordati. Richard Pascoe, Chief Executive Officer of Apricus, com... 
Event Calendarmore >
September 2016?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
Presentations
52 Week High
Today
SMTWTFS
-4-3-2-1123
45678910
11121314151617
18192021222324
2526
09/26/16
424B5
Formats:  Excel HTML Adobe PDF Word
8-K
Formats:  Excel HTML Adobe PDF Word
2728
09/28/16
Apricus Biosciences Closes $3.7 Million Registered Direct Offering
8-K/A
Formats:  Excel HTML Adobe PDF Word
8-K
Formats:  Excel HTML Adobe PDF Word
424B5
Formats:  Excel HTML Adobe PDF Word
293051
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Apricus Biosciences, Inc. posts new information to the site. Just enter your e-mail address and click Submit.